122 related articles for article (PubMed ID: 7538974)
1. Tenascin-C in serum: a questionable tumor marker.
Schenk S; Muser J; Vollmer G; Chiquet-Ehrismann R
Int J Cancer; 1995 May; 61(4):443-9. PubMed ID: 7538974
[TBL] [Abstract][Full Text] [Related]
2. Tenascin-C in serum: an acute-phase protein or a carcinoma marker?
Schenk S; Muser J; Vollmer G; Chiquet-Ehrismann R
Int J Cancer; 1995 Jan; 60(1):145. PubMed ID: 7529210
[No Abstract] [Full Text] [Related]
3. Significance of tenascin serum level as tumor marker in primary colorectal carcinoma.
Riedl S; Bodenmüller H; Hinz U; Holle R; Möller P; Schlag P; Herfarth C; Faissner A
Int J Cancer; 1995 Feb; 64(1):65-9. PubMed ID: 7545144
[TBL] [Abstract][Full Text] [Related]
4. Development and application of an enzyme immunoassay for tenascin.
Washizu K; Kimura S; Hiraiwa H; Matsunaga K; Kuwabara M; Ariyoshi Y; Kato K; Takeuchi K
Clin Chim Acta; 1993 Oct; 219(1-2):15-22. PubMed ID: 7508343
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.
Degen M; Brellier F; Schenk S; Driscoll R; Zaman K; Stupp R; Tornillo L; Terracciano L; Chiquet-Ehrismann R; Rüegg C; Seelentag W
Int J Cancer; 2008 Jun; 122(11):2454-61. PubMed ID: 18306355
[TBL] [Abstract][Full Text] [Related]
6. Serum tenascin levels in chronic liver disease.
Yamauchi M; Mizuhara Y; Maezawa Y; Toda G
Liver; 1994 Jun; 14(3):148-53. PubMed ID: 7521506
[TBL] [Abstract][Full Text] [Related]
7. Rapid increase in plasma tenascin-C concentration after isolated limb perfusion with high-dose tumor necrosis factor (TNF), interferon gamma (IFN gamma) and melphalan for regionally advanced tumors.
Schienk S; Liénard D; Gerain J; Baumgartner M; Lejeune FJ; Chiquet-Ehrismann R; Rüegg C
Int J Cancer; 1995 Nov; 63(5):665-72. PubMed ID: 7591283
[TBL] [Abstract][Full Text] [Related]
8. Tenascin in breast cancer development--is epithelial tenascin a marker for poor prognosis?
Yoshida T; Ishihara A; Hirokawa Y; Kusakabe M; Sakakura T
Cancer Lett; 1995 Mar; 90(1):65-73. PubMed ID: 7536626
[TBL] [Abstract][Full Text] [Related]
9. Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumour.
Yoshida J; Wakabayashi T; Okamoto S; Kimura S; Washizu K; Kiyosawa K; Mokuno K
J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1212-5. PubMed ID: 7523604
[TBL] [Abstract][Full Text] [Related]
10. Murine tenascin: cDNA cloning, structure and temporal expression of isoforms.
Saga Y; Tsukamoto T; Jing N; Kusakabe M; Sakakura T
Gene; 1991 Aug; 104(2):177-85. PubMed ID: 1717349
[TBL] [Abstract][Full Text] [Related]
11. Tenascin expression in astrocytomas correlates with angiogenesis.
Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA
Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617
[TBL] [Abstract][Full Text] [Related]
12. Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?
Rohm I; Grün K; Müller LM; Kretzschmar D; Fritzenwanger M; Yilmaz A; Lauten A; Jung C; Schulze PC; Berndt A; Franz M
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117120
[TBL] [Abstract][Full Text] [Related]
13. Expression of tenascin during carcinogenesis and involution of hormone-dependent tissues.
Vollmer G
Biochem Cell Biol; 1994; 72(11-12):505-14. PubMed ID: 7544587
[TBL] [Abstract][Full Text] [Related]
14. Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression.
Leprini A; Querzé G; Zardi L
Perspect Dev Neurobiol; 1994; 2(1):117-23. PubMed ID: 7530138
[TBL] [Abstract][Full Text] [Related]
15. Postmortem serum tenascin-C (TN-C) concentrations in forensic autopsy cases: A pilot study.
Ohtsu Y; Sasao A; Yonemitsu K; Nishitani Y
Leg Med (Tokyo); 2013 Mar; 15(2):61-5. PubMed ID: 23043956
[TBL] [Abstract][Full Text] [Related]
16. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways.
Rettig WJ; Erickson HP; Albino AP; Garin-Chesa P
J Cell Sci; 1994 Feb; 107 ( Pt 2)():487-97. PubMed ID: 7515896
[TBL] [Abstract][Full Text] [Related]
17. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C.
Matsumoto K; Saga Y; Ikemura T; Sakakura T; Chiquet-Ehrismann R
J Cell Biol; 1994 Apr; 125(2):483-93. PubMed ID: 7512972
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation.
Chockalingam PS; Glasson SS; Lohmander LS
Osteoarthritis Cartilage; 2013 Feb; 21(2):339-45. PubMed ID: 23142724
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues.
Natali PG; Nicotra MR; Bigotti A; Botti C; Castellani P; Risso AM; Zardi L
Int J Cancer; 1991 Apr; 47(6):811-6. PubMed ID: 1707033
[TBL] [Abstract][Full Text] [Related]
20. Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis.
Hasegawa M; Nakoshi Y; Muraki M; Sudo A; Kinoshita N; Yoshida T; Uchida A
J Orthop Res; 2007 May; 25(5):563-8. PubMed ID: 17262825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
